02/14/2025
5:13 PM | Astria Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
2:45 PM | Astria Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
7:46 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025
7:09 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
6:45 AM | Astria Therapeutics (Subject)
ForGrowth III PA B.V. (Filed by)
| Form SCHEDULE 13G | |
11/14/2024
4:45 PM | Astria Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | Astria Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
11:03 AM | Astria Therapeutics (Subject)
Vestal Point Capital, LP (Filed by)
| Form SC 13G | |
11/13/2024
3:01 PM | Astria Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
12:29 PM | Astria Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
1:17 PM | Astria Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
Get the Latest News and Ratings for ATXS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/04/2024
11:37 AM | Astria Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:39 AM | Astria Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:39 AM | Astria Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:05 PM | Astria Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G | |
10/24/2024
1:02 PM | Astria Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
08/12/2024
3:56 PM | Astria Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/10/2024
9:10 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
04/22/2024
3:06 PM | Astria Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:08 PM | Astria Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:10 PM | Astria Therapeutics (Filer)
| Form ARS | |
04/09/2024
7:07 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
7:09 AM | AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
7:11 AM | AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:37 AM | Astria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:19 AM | Astria Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
03/07/2024
11:29 AM | Astria Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
